Serum sphingomyelin levels are related to the clearance of postprandial remnant-like particles

Journal of Lipid Research

Volumn 46, Issue 2, 2005, Pages 196-200

  Schlitt, Axel ^a   Hojjati, Mohammad R ^a   Von Gizycki, Hans ^a   Lackner, Karl J ^b   Blankenberg, Stefan ^b   Schwaab, Bernhard ^c   Meyer, Juergen ^b   Rupprecht, Hans J ^b   Jiang, Xian Cheng ^a  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c Curschmann Clinic   (Germany)

Author keywords

Atherosclerosis; Lipid; Lipoprotein

Indexed keywords

APOLIPOPROTEIN B; CHYLOMICRON; HIGH DENSITY LIPOPROTEIN; SPHINGOMYELIN; TRIACYLGLYCEROL;

ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; LIPID DIET; METABOLIC RATE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

APOLIPOPROTEINS B; ARTERIOSCLEROSIS; BIOLOGICAL MARKERS; CHOLESTEROL; CHOLESTEROL, HDL; CHYLOMICRONS; HUMANS; LIPOPROTEINS, HDL; POSTPRANDIAL PERIOD; SPHINGOMYELINS; TIME FACTORS; TRIGLYCERIDES;

EID: 13944259664     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.C400011-JLR200     Document Type: Article

References (25)

1. Merrill, A. H., Jr., and D. D. Jones. 1990. An update of the enzymology and regulation of sphingomyelin metabolism. Biochim. Biophys. Acta. 1044: 1-12.
2. Marathe, S., G. Kuriakose, K. J. Williams, and I. Tabes. 1999. Sphingomyelinase, an enzyme implicated in atherogenesis, is present in atherosclerotic lesions and binds to specific components of the subendothelial extracellular matrix. Arterioscler. Thromb. Vasc. Biol. 19: 2648-2658.
3. Chapman, M. J. 1986. Comparative analysis of mammalian plasma lipoproteins. Methods Enzymol. 128: 70-143.
4. Gianturco, S. H., and W. A. Bradley. 1999. Pathophysiology of triglyceride-rich lipoproteins in atherothrombosis: cellular aspects. Clin. Cardiol. 22: II7-II14.
5. Takeichi, S., N. Yukawa, Y. Nakajima, M. Osawa, T. Saito, Y. Seto, T. Nakano, A. R. Saniabadi, M. Adachi, T. Wang, and K. Nakajima. 1999. Association of plasma triglyceride-rich lipoprotein remnants with coronary atherosclerosis in cases of sudden cardiac death. Atherosclerosis. 142: 309-315.
6. Schissel, S. L., X. C. Jiang, J. Tweedie-Hardman, T. Jeong, E. H. Camejo, J. Najib, J. H. Rapp, K. J. Williams, and I. Tabas. 1998. Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH. J. Biol. Chem. 273: 2738-2746.
7. Schissel, S. L., J. Tweedie-Hardman, J. H. Rapp, G. Graham, K. J. Williams, and I. Tabas. 1996. Rabbit aorta and human atherosclerotic lesions hydrolyze the sphingomyelin of retained low-density lipoprotein. Proposed role for arterial-wall sphingomyelinase in subendothelial retention and aggregation of atherogenic lipoproteins. J. Clin. Invest. 98: 1455-1464.
8. Jiang, X. C., F. Paultre, T. A. Pearson, R. G. Reed, C. K. Francis, M. Lin, L. Berglund, and A. R. Tall. 2000. Plasma sphingomyelin level as a risk factor for coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 20: 2614-2618.
9. Nakajima, K., T. Saito, A. Tamura, M. Suzuki, T. Nakano, M. Adachi, A. Tanaka, N. Tada, H. Nakamura, and E. Campos. 1993. Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gels. Clin. Chim. Acta. 223: 53-71.
10. Mjos, O. D., O. Faergeman, R. L. Hamilton, and R. J. Havel. 1975. Characterization of remnants produced during the metabolism of triglyceride-rich lipoproteins of blood plasma and intestinal lymph in the rat. J. Clin. Invest. 56: 603-615.
11. Karpe, F., and A. Hamsten. 1995. Postprandial lipoprotein metabolism and atherosclerosis. Curr. Opin. Lipidol. 6: 123-129.
12. Ginsberg, H. N., J. Jones, W. S. Blaner, A. Thomas, W. Karmally, L. Fields, D. Blood, and M. D. Begg. 1995. Association of postprandial triglyceride and retinyl palmitate responses with newly diagnosed exercise-induced myocardial ischemia in middle-aged men and women. Arterioscler. Thromb. Vasc. Biol. 15: 1829-1838.
13. Krauss, R. M. 1998. Atherogenicity of triglyceride-rich lipoproteins. Am. J. Cardiol. 81: 13B-17B.
14. Tanaka, A., M. Ai, Y. Kobayashi, M. Tamura, K. Shimokado, and F. Numano. 2001. Metabolism of triglyceride-rich lipoproteins and their role in atherosclerosis. Ann. NY Acad. Sci. 947: 207-212.
15. Karpe, F., S. Boquist, R. Tang, G. M. Bond, U. de Faire, and A. Hamsten. 2001. Remnant lipoproteins are related to intima-media thickness of the carotid artery independently of LDL cholesterol and plasma triglycerides. J. Lipid Res. 42: 17-21.
16. Hopkins, P. N., S. C. Hunt, L. L. Wu, G. H. Williams, and R. R. Williams. 1996. Hypertension, dyslipidemia, and insulin resistance: links in a chain or spokes on a wheel? Curr. Opin. Lipidol. 7: 241-253.
17. Weintraub, M. S., S. Eisenberg, and J. L. Breslow. 1987. Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E. J. Clin. Invest. 80: 1571-1577.
18. Jeong, T. S., S. L. Schissel, I. Tabas, H. J. Pownall, A. R. Tall, and X. C. Jiang. 1998. Increased sphingomyelin content of plasma lipoproteins in apolipoprotein E knockout mice reflects combined production and catabolic defects and enhances reactivity with mammalian sphingomyelinase. J. Clin. Invest. 101: 905-912.
19. Van Lenten, B. J., A. M. Fogelman, R. L. Jackson, S. Shapiro, M. E. Haberland, and P. A. Edwards. 1985. Receptor-mediated uptake of remnant lipoproteins by cholesterol-loaded human monocyte-macrophages. J. Biol. Chem. 260: 8783-8788.
20. Gianturco, S. H., F. B. Brown, A. M. Gotto, Jr., and W. A. Bradley. 1982. Receptor-mediated uptake of hypertriglyceridemic very low density lipoproteins by normal human fibroblasts. J. Lipid Res. 23: 984-993.
21. Van Lenten, B. J., A. M. Fogelman, M. M. Hokom, L. Benson, M. E. Haberland, and P. A. Edwards. 1983. Regulation of the uptake and degradation of beta-very low density lipoprotein in human monocyte macrophages. J. Biol. Chem. 258: 5151-5157.
22. Georgopoulos, A., S. D. Kafonek, and I. Raikhel. 1994. Diabetic postprandial triglyceride-rich lipoproteins increase esterified cholesterol accumulation in THP-1 macrophages. Metabolism. 43: 1063-1072.
23. Yu, K. C., and J. C. Mamo. 2000. Chylomicron-remnant-induced foam cell formation and cytotoxicity: a possible mechanism of cell death in atherosclerosis. Clin. Sci. (Lond.). 98: 183-192.
24. Plump, A. S., J. D. Smith, T. Hayek, K. Aalto-Setala, A. Walsh, J. G. Verstuyft, E. Rubin, and J. L. Breslow. 1992. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 71: 343-353.
25. Yla-Herttuala, S., W. Palinski, M. E. Rosenfeld, S. Parthasarathy, T. E. Carew, S. Butler, J. L. Witztum, and D. Steinberg. 1989. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest. 84: 1086-1095.